Latest News and Press Releases
Want to stay updated on the latest news?
-
MINK intersects 7.1 meters of 0.44% Ni, 0.28% Cu, 0.06% Co in massive sulphide at Warren Property, Timmins, Ontario
-
Mink Ventures Completes Montcalm Drill Program
-
Mink Completes Drilling at Warren Ni Cu Co Project; Moves Drill to Montcalm Ni Cu Co Project to Test Priority One Target
-
Diamond Drilling Underway at Mink Ventures' Warren Ni Cu Co Property
-
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into transplantation with an off-the-shelf, HLA-independent,...
-
Mink Ventures Provides Update
-
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies...
-
MINK Ventures Corp. Closes Non Brokered Private Placement; Raises Gross Proceeds of $857,518.
-
MINK Ventures Corp. Closes $731,518 in First Tranche of Non-Brokered Private Placement
-
MINK VENTURES UPSIZES PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT UP T0 $1,000,000